NetworkNewsBreaks

ThursdayJan 04, 2024 2:17 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Releases Shareholder Letter

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (“I&I”) biological products, has released a letter from its CEO, Amir Reichman. In the letter, Reichman summarizes the company’s 2023 accomplishments and looks forward to 2024. According to the letter, company highlights for the year include a recently completed ex-vivo study that indicates the potential of SCNI’s anti-IL-17 VHH antibody (“NanoAb”) to effectively and conveniently treat mild to moderate plaque psoriasis; the launch of Scinai Bioservices, the company’s boutique, end-to-end CDMO (“CDMO”) business unit, which will focus on assisting biotech companies to bring their products to market; capital infusions that…

Continue Reading

ThursdayJan 04, 2024 2:05 pm

NetworkNewsBreaks — Tuttle Capital Daily 2X Inverse Regional Banks ETF (NASDAQ: SKRE) Announces 2x Inverse Regional Bank ETF, Begins Trading

Tuttle Capital Daily 2x Inverse Regional Bank ETF (NASDAQ: SKRE) commences trading on the NASDAQ Exchange, starting today. According to the announcement, the fund is designed to use swaps to gain inverse daily two-times exposure to the SPDR S&P Regional Banking ETF. “This year saw a number of regional banks go under,” said Tuttle Capital CEO Matthew Tuttle in the press release. “These guys are not too big to fail, when they start to have problems, things can spiral quickly, and nobody is going to bail them out. . . . .This product is in line with our goal of…

Continue Reading

ThursdayJan 04, 2024 12:25 pm

NetworkNewsBreaks – Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) Announces Pricing of US$20M Public Offering

Profound Medical (TSX: PRN) (NASDAQ: PROF) recently announced the pricing of its underwritten public offering of 2,666,667 common shares, each at a price to the public of US$7.50, led by health care-focused institutional investors. Of approximately US$20,000,000 in gross proceeds from the offering, the company intends to use net proceeds to fund the continued commercialization of the TULSA-PRO(R) system in the United States, to fund the continued development and commercialization of the TULSA-PRO system and the Sonalleve(R) system globally, as well as for working capital and general corporate purposes. Titan Partners Group, a division of American Capital Partners, is acting as…

Continue Reading

ThursdayJan 04, 2024 12:14 pm

NetworkNewsBreaks — Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Announces Acquisition of Louisiana Facility for Future REE Processing Plant

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a leading developer of rare earth element (“REE”) processing technology, has acquired an 80,800-square-foot brownfield facility in Alexandria, Louisiana. The company plans to use the structure, which is located on a 10-plus acre industrial parcel, for the development of its first commercial rare earth element (“REE”) processing facility. According to the announcement, Ucore has entered into a multidecade lease for the property with the England Economic and Industrial Development District (“EEIDD”). The facility is situated at the England Airpark, which is a former Air Force base dedicated to generating economic development in central Louisiana. Ucore…

Continue Reading

ThursdayJan 04, 2024 9:45 am

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) CEO Releases Shareholder Letter Outlining Opportunities, Challenges, Processes

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, has released a shareholder letter from chair and CEO Jim Joyce. In the letter, whose objective is to help shareholders better understand SIGY opportunities, challenges and decision-making processes, Joyce reiterates the company’s long-term objective of building an enduring organization whose therapies save lives. The letter included an update on the company’s proposed underwritten financing and then discussed in detail the company’s portfolio of new therapies. “Our endeavors today are comprised of Sigyn Therapy(TM) to address pathogen-associated inflammatory disorders, the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic antibodies, ChemoPrep(TM) to improve the delivery of…

Continue Reading

ThursdayJan 04, 2024 9:16 am

NetworkNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Partners with Online Tree-Planting Platform to Plant Trees in Kenya

Diamond Lake Minerals (OTC: DLMI), a leading player in the digital asset landscape bridging the gap between traditional finance and decentralized finance, has initiated the planting of 500 mangrove trees in Kenya. DLMI is partnering with Evertreen in this tree-planting initiative; the trees planted are expected to absorb 154 tons of CO2 over their lifespan. DLMI’s partnership with Evertreen addresses deforestation, supports habitat protection and advances sustainable development goals established by the United Nations. In addition, the company will continue to plant trees every month, with the objective of planting millions of trees over the next decade. The company opted to plant mangroves…

Continue Reading

WednesdayJan 03, 2024 3:06 pm

NetworkNewsBreaks – IBN to Serve as Official Media Partner for ‘Web3 Is A Joke in San Francisco’

IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announced its continued collaboration with Mona Shaikh, a trailblazing comedian, commentator and producer of the acclaimed “Web3 Is A Joke” series. IBN was designated the official media partner for the upcoming “Web3 Is A Joke in San Francisco” event, slated to take place at Canopy Jackson Square in San Francisco on Friday, Jan. 26, 2024. “Web3 Is A Joke in San Francisco,” simultaneously entertaining and educational, will feature a lineup of notable comedians and influential personalities for a lively comedy roast on all things Web3 while offering an ideal platform for networking…

Continue Reading

WednesdayJan 03, 2024 12:48 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reaches Class 3 Delivery Target for 2023 Calendar Year

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting that it reached its Class 3 target for the calendar year 2023. According to the announcement, the company built 154 Class 3 vehicles and delivered 141 Class 3 vehicles to the Randy Marion Automotive Group (“RMA”) for a total invoiced amount of $9,196,021; the company noted that the remaining 13 vehicles are being utilized for engineering and marketing purposes. Production of the Mullen Three takes place in the company’s Tunica, Mississippi-based commercial vehicle facility; the Mullen ONE, Class 1 EV cargo van and Class 3 EV cab chassis…

Continue Reading

TuesdayJan 02, 2024 2:14 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Leveraging Momentum Based on ‘Successful Execution of Growth Strategy’

SuperCom Ltd. (NASDAQ: SPCB), a leading global provider of traditional and digital identity solutions, recently reported positive financial and operating results for the third quarter of the 2023 financial year (“Q3 2023”). “Revenue for Q3 2023 stood at $6.8 million, up from $6.3 million in Q3 2022. Gross profit saw an 89% year-over-year (‘YOY’) growth to $4.0 million from $2.1 million in 2022, while operating income improved by 200% to $0.8 million, up from a $0.8 million operating loss the previous year. For the nine months ending Sept. 30, 2023, SuperCom’s revenue grew by 67%, with gross profit seeing a…

Continue Reading

TuesdayJan 02, 2024 1:31 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Delivers 50 Additional Class 1 EV Cargo Vans to Randy Marion Automotive Group

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its delivery of 50 additional Class 1 EV cargo vans to Randy Marion Automotive Group (“RMA” or “Randy Marion”), invoicing RMA for $1,681,750. To date, Mullen has delivered 100 Class 1 cargo vans for a total invoiced amount of $3,363,500 and is on target to deliver a total of 285 Class 1 vehicles by Jan. 8, 2024. “We ended 2023 with an emphasis on delivering Class 1 and Class 3 vehicles and are now ramping up production to meet the commitments we have for the 2024 demands of…

Continue Reading